EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of α ‐Mangostin on the Pharmacokinetic Profile of Tofacitinib in Rats Both In Vitro and In Vivo

Jiange Yao, Zebei Lu, Quan Zhou, Abdullah Al Mamun iD, Yaru Shi, Shuanghu Wang iD, Ying Yao

Biopharmaceutics & Drug Disposition · 2025

DOI: 10.1002/bdd.70012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, 2025. Verfasst von Jiange Yao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Outpatient, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China. Hauptthemen laut MEDLINE: Pyrimidines, Piperidines, Protein Kinase Inhibitors, Xanthones. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Public Welfare Technology Research Funding Project of Zhejiang, Public Welfare Technology Research Funding Project of Lishui, Medical and Health Science and Technology Plan Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the effects of α ‐mangostin ( α ‐MG) on the pharmacokinetics of tofacitinib in vitro and in vivo, aiming to recommend its appropriate application in clinical practice. To investigate the values of IC 50 and inhibition of α ‐MG in vitro, rat liver microsomes were incubated with tofacitinib. In this study, Sprague–Dawley rats were randomly assigned to three groups: a control group, a single‐dose group (50 mg/kg of α ‐MG), and a multiple‐dose group (50 mg/(kg/d) of α ‐MG for 7 days). Tofacitinib (10 mg/kg) was administered 30 min after the intervention of α ‐MG to each group. The plasma was collected from the caudal vein at different time points and in heparinized tubes. Tofacitinib metabolites in the plasma were determined by UPLC‐MS/MS. Further analyses were conducted utilizing Pymol molecular docking simulation to evaluate the effect of α ‐MG on tofacitinib. Our results showed that MG inhibited the metabolism of tofacitinib in vitro by exhibiting both competitive and noncompetitive inhibition. More importantly, we found that multiple‐dose administration of α ‐MG significantly increased the AUC (0–12h) , AUC (0–∞), and C max , prolonged the t 1/2 and shortened the MRT (0–12h) and MRT (0–∞) of tofacitinib. At the same time, the CL z/F was decreased, which was consistent with the results of in vitro experiments. Furthermore, we observed no significant difference between single‐dose and multiple‐dose groups. Intriguingly, α ‐MG and tofacitinib were close at the CYP3A4 spatial location. In summary, our investigation demonstrated that α ‐MG significantly impacts the metabolism of tofacitinib both in vitro and in vivo, suggesting potential herb–drug interactions (HDIs). The use of tofacitinib with herbs containing MG should be monitored clinically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesPiperidinesProtein Kinase InhibitorsXanthonesPyrrolesAnimalsRats, Sprague-DawleyMaleMicrosomes, LiverMolecular Docking SimulationRatsDrug Interactions

Stichwörter der Autor:innen

herb–drug interactionspharmacokineticstofacitinibα‐mangostin

Substanzen

tofacitinibPyrimidinesmangostinPiperidinesProtein Kinase InhibitorsXanthonesPyrroles

Autor:innen und Institutionen

  • Department of Outpatient, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, China.
  • Key Laboratory of Joint Diagnosis and Treatment of Chronic Liver Disease and Liver Cancer of Lishui, Central Laboratory of The Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui Unive…

ORCID-Profile: Abdullah Al Mamun, Shuanghu Wang

Förderung

  • Public Welfare Technology Research Funding Project of Zhejiang
  • Public Welfare Technology Research Funding Project of Lishui
  • Medical and Health Science and Technology Plan Project of Zhejiang Province

Zitieren

APA

Yao, J., Lu, Z., Zhou, Q., Mamun, A. A., Shi, Y., Wang, S., & Yao, Y. (2025). The Effect of α ‐Mangostin on the Pharmacokinetic Profile of Tofacitinib in Rats Both In Vitro and In Vivo. Biopharmaceutics & Drug Disposition. https://doi.org/10.1002/bdd.70012

Vancouver

Yao J, Lu Z, Zhou Q, Mamun AA, Shi Y, Wang S, et al. The Effect of α ‐Mangostin on the Pharmacokinetic Profile of Tofacitinib in Rats Both In Vitro and In Vivo. Biopharmaceutics & Drug Disposition. 2025. doi:10.1002/bdd.70012

BibTeX
@article{Yao2025,
  author = {Yao, Jiange and Lu, Zebei and Zhou, Quan and Mamun, Abdullah Al and Shi, Yaru and Wang, Shuanghu and Yao, Ying},
  title = {The Effect of α ‐Mangostin on the Pharmacokinetic Profile of Tofacitinib in Rats Both In Vitro and In Vivo},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2025},
  doi = {10.1002/bdd.70012}
}
Kostenlos starten →